CORRELATION OF CLINICAL RESPONSE WITH PATIENT-REPORTED OUTCOMES IN THE AMPLE (ABATACEPT VERSUS ADALIMUMAB COMPARISON IN BIOLOGIC-NAIVE RA PATIENTS WITH BACKGROUND METHOTREXATE) TRIAL: 2-YEAR RESULTS

被引：0
|
作者：
Fleischmann, R. [1 ]
Weinblatt, M. [2 ]
Schiff, M. [3 ]
Khanna, D. [4 ]
Maldonado, M. [5 ]
Nadkarni, A. [5 ]
Fay, J. [5 ]
Furst, D. [6 ]
机构：
[1] Univ Texas SW Med Ctr Dallas, Dallas, TX 75390 USA
[2] Brigham & Womens Hosp, Boston, MA 02115 USA
[3] Univ Colorado, Denver, CO 80202 USA
[4] Univ Michigan, Ann Arbor, MI 48109 USA
[5] Bristol Myers Squibb Co, Princeton, NJ USA
[6] Univ Calif Los Angeles, Los Angeles, CA USA
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2014年 / 73卷
关键词：
D O I：
10.1136/annrheumdis-2014-eular.2113
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
SAT0246
引用
收藏
页码：681 / 682
页数：2
相关论文
共 50 条
  • [1] 2-Year Results From The Ample (Abatacept versus Adalimumab Comparison in Biologic-Naive RA Patients with Background Methotrexate) Trial: Changes In Patient-Reported Outcomes In Response To Subcutaneous Abatacept Or Adalimumab In Rheumatoid Arthritis
    Fleischmann, R.
    Weinblatt, M. E.
    Schiff, M.
    Khanna, D.
    Maldonado, M. A.
    Nadkarni, A.
    Furst, D. E.
    [J]. ARTHRITIS AND RHEUMATISM, 2013, 65 : S183 - S183
  • [2] 2-Year Results from the AMPLE (Abatacept versus Adalimumab Comparison in Biologic-Naive RA Patients with Background Methotrexate) Trial: Changes in Patient-Reported Outcomes in Response to Subcutaneous Abatacept or Adalimumab in Rheumatoid Arthritis
    Fleischmann, Roy
    Weinblatt, Michael
    Schiff, Michael
    Khanna, Dinesh
    Maldonado, Michael
    Nadkarni, Anagha
    Furst, Daniel
    [J]. JOURNAL OF RHEUMATOLOGY, 2014, 41 (07) : 1475 - 1476
  • [3] Changes in Patient-Reported Outcomes in Response to Subcutaneous Abatacept or Adalimumab in Rheumatoid Arthritis: Results from the AMPLE (Abatacept Versus Adalimumab Comparison in Biologic-Naive RA Subjects with Background Methotrexate) Trial
    Maldonado, Michael
    Fleischmann, Roy
    Weinblatt, Michael
    Schiff, Michael
    Khanna, Dinesh
    Furst, Daniel
    [J]. JOURNAL OF RHEUMATOLOGY, 2013, 40 (06) : 1006 - 1006
  • [4] CLINICAL RESPONSES BY BASELINE RA DISEASE DURATION IN THE AMPLE (ABATACEPT VERSUS ADALIMUMAB COMPARISON IN BIOLOGIC-NAIVE RA PATIENTS WITH BACKGROUND METHOTREXATE) TRIAL: 2-YEAR RESULTS
    Schiff, M.
    Weinblatt, M. E.
    Valente, R.
    van der Heijde, D.
    Citera, G.
    Maldonado, M. A.
    Fay, J.
    Fleischmann, R.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2014, 73 : 387 - 388
  • [5] CHANGES IN PATIENT-REPORTED OUTCOMES IN RESPONSE TO SUBCUTANEOUS ABATACEPT OR ADALIMUMAB IN RHEUMATOID ARTHRITIS: RESULTS FROM THE AMPLE (ABATACEPT VS ADALIMUMAB COMPARISON IN BIOLOGIC-NAIVE RA SUBJECTS WITH BACKGROUND METHOTREXATE) TRIAL
    Fleischmann, Roy
    Weinblatt, Michael E.
    Schiff, Michael H.
    Khanna, Dinesh
    Furst, Daniel E.
    Maldonado, Michael A.
    [J]. RHEUMATOLOGY, 2013, 52 : 87 - 87
  • [6] CHANGES IN PATIENT REPORTED OUTCOMES IN RESPONSE TO SUBCUTANEOUS ABATACEPT OR ADALIMUMAB IN RHEUMATOID ARTHRITIS: RESULTS FROM THE AMPLE (ABATACEPT VERSUS ADALIMUMAB COMPARISON IN BIOLOGIC NAIVE RA SUBJECTS WITH BACKGROUND METHOTREXATE) TRIAL
    Fleischmann, R.
    Weinblatt, M.
    Schiff, M.
    Khanna, D.
    Furst, D.
    Maldonado, M.
    [J]. INTERNAL MEDICINE JOURNAL, 2013, 43 : 10 - 11
  • [7] Changes in Patient Reported Outcomes in Response to Subcutaneous Abatacept or Adalimumab in Rheumatoid Arthritis: Results From the Ample (Abatacept Versus Adalimumab Comparison in Biologic Naive RA Subjects with Background Methotrexate) Trial.
    Fleischmann, Roy
    Weinblatt, Michael E.
    Schiff, Michael H.
    Khanna, Dinesh
    Furst, Daniel
    Maldonado, Michael A.
    [J]. ARTHRITIS AND RHEUMATISM, 2012, 64 (10): : S578 - S578
  • [8] Head-To-Head Comparison Of Subcutaneous Abatacept Versus Adalimumab On Background Methotrexate In RA: Blinded Two Year Results From The Ample (Abatacept Versus Adalimumab Comparison in Biologic-Naive RA Subjectswith Background Methotrexate) study
    Weinblatt, Michael E.
    Schiff, Michael H.
    Valente, Robert
    van der Heijde, Desiree M.
    Citera, Gustavo
    Elegbe, Ayanbola
    Maldonado, Michael A.
    Fleischmann, Roy M.
    [J]. ARTHRITIS AND RHEUMATISM, 2013, 65 : S991 - S992
  • [9] Head-To-Head Comparison of Subcutaneous Abatacept Versus Adalimumab on Background Methotrexate in RA: Blinded Two-Year Results from the AMPLE (Abatacept Versus Adalimumab Comparison in Biologic-Naive RA Subjects with Background Methotrexate) Study
    Weinblatt, Michael
    Schiff, Michael
    Valente, Robert
    van der Heijde, Desiree
    Citera, Gustavo
    Elegbe, Ayanbola
    Maldonado, Michael
    Fleischmann, Roy
    [J]. JOURNAL OF RHEUMATOLOGY, 2014, 41 (07) : 1476 - 1476
  • [10] EFFECTS OF SUBCUTANEOUS ABATACEPT OR ADALIMUMAB ON REMISSION AND ASSOCIATED CHANGES IN PHYSICAL FUNCTION AND RADIOGRAPHIC OUTCOMES: ONE YEAR RESULTS FROM THE AMPLE (ABATACEPT VERSUS ADALIMUMAB COMPARISON IN BIOLOGIC-NAIVE RA SUBJECTS WITH BACKGROUND METHOTREXATE) TRIAL
    Fleischmann, R.
    Schiff, M.
    Weinblatt, M.
    Maldonado, M.
    Massarotti, E.
    Yazici, Y.
    [J]. INTERNAL MEDICINE JOURNAL, 2013, 43 : 11 - 11
12345